[1]陈秋宇 冷冰 邹东娜 吴继超 卢翠翠.甲泼尼龙静脉冲击治疗Graves眼病致窦性心动过缓 1例并文献复习[J].国际内分泌代谢杂志,2020,40(02):142-144.[doi:10.3760/cma.j.issn.1673-4157.2020.02.017]
　Chen Qiuyu,Leng Bing,Zou Dongna,et al.A case of sinus bradycardia induced by pulsed intravenous methylprednisolone for treating Graves' orbitopathy and literatures review[J].International Journal of Endocrinology and Metabolism,2020,40(02):142-144.[doi:10.3760/cma.j.issn.1673-4157.2020.02.017]

点击复制

甲泼尼龙静脉冲击治疗Graves眼病致窦性心动过缓 1例并文献复习()

分享到：

参考文献/References:

[1] Ross DS,Burch HB,Cooper DS,et al. 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis[J].Thyroid,2016,26(10):1343-1421.DOI:10.1089/thy. 2016.0229.
[2] Kahaly GJ,Bartalena L,Hegedüs L,et al.2018 European thyroid association guideline for the management of Graves' hyperthyroidism[J].Eur Thyroid J,2018,7(4):167-186.DOI:10.1159/000490384.
[3] Manitpisitkul P,Curtin CR,Shalayda K,et al.Pharmacokinetic interactions between topiramate and diltiazem, hydrochlorothiazide, or propranolol[J].Clin Pharmacol Drug Dev,2014,3(5):378-387.DOI:10.1002/cpdd.107.
[4] Bartalena L,Baldeschi L,Boboridis K,et al.The 2016 European thyroid association/european group on Graves' orbitopathy guidelines for the management of Graves' orbitopathy[J].Eur Thyroid J,2016,5(1):9-26.DOI:10.1159/000443828.
[5] Zang S,Ponto KA,Kahaly GJ.Clinical review: intravenous glucocorticoids for Graves' orbitopathy:efficacy and morbidity[J].J Clin Endocrinol Metab,2011,96(2):320-332.DOI:10.1210/jc.2010-1962.
[6] Zhu W,Ye L,Shen L,et al.A prospective, randomized trial of intravenous glucocorticoids therapy with different protocols for patients with Graves' ophthalmopathy[J].J Clin Endocrinol Metab,2014,99(6):1999-2007.DOI:10.1210/jc.2013-3919.
[7] Bartalena L,Krassas GE,Wiersinga W,et al.Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy[J].J Clin Endocrinol Metab,2012,97(12):4454-4463.DOI:10.1210/jc.2012-2389.
[8] Stiebel-Kalish H,Robenshtok E,Hasanreisoglu M,et al.Treatment modalities for Graves' ophthalmopathy:systematic review and meta analysis[J].J Clin Endocrinol Metab,2009,94(8):2708-2716.DOI:10.1210/jc.2009-0376.
[9] Vasheghani-Farahani A,Sahraian MA,Darabi L,et al.Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis[J].J Neurol Sci,2011,309(1-2):75-78.DOI:10.1016/j.jns.2011.07.018.
[10] Beyan E,Urün Y,Uzuner A.Bradycardia due to methylprednisolone therapy[J].J Clin Rheumatol,2004,10(4):230.DOI:10.1097/01.rhu.0000135562.11724.60.
[11] Lucas KG,Howrie DL,Phebus CK.Cardiorespiratory decompensation following methylprednisolone administration[J].Pediatr Hematol Oncol,1993,10(3):249-255.DOI:10.3109/08880019309029492.
[12] Fujimoto S,Kondoh H,Yamamoto Y,et al.Holter electrocardiogram monitoring in nephrotic patients during methylprednisolone pulse therapy[J].Am J Nephrol,1990,10(3):231-236.DOI:10.1159/000168087.
[13] Akikusa JD,Feldman BM,Gross GJ,et al.Sinus bradycardia after intravenous pulse methylprednisolone[J].Pediatrics,2007,119(3):e778-e782.DOI:10.1542/peds.2006-0029.
[14] Kumari R,Uppal SS.First report of supraventricular tachycardia after intravenous pulse methylprednisolone therapy, with a brief review of the literature[J].Rheumatol Int,2005,26(1):70-73.DOI:10.1007/s00296-005-0589-7.
[15] Guillén EL,Ruíz AM,Bugallo JB.Hypotension, bradycardia, and asystole after high-dose intravenous methylprednisolone in a monitored patient[J].Am J Kidney Dis,1998,32(2):E4.DOI:10.1053/ajkd.1998.v32.pm10074612.